Abstract
Amyotrophic lateral sclerosis is a rare, degenerative neuromuscular disease, leading to progressive loss of muscle function, and ultimately death. The King’s and MiToS staging systems are used for assessing clinical progression, which is typically rapid. Real-world research quantifying health-related quality of life (HRQoL) at different disease stages is limited.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
